Search Results

The need for superior speed, agility, resiliency, and product innovation continues to push enterprises to adopt cloud solutions. To optimize their use of cloud and maximize benefits, enterprises are increasingly pushing industry-specific workloads to cloud to realize user experience and […]

In the current outsourcing climate, organizations need to consider an evolving mix of providers, locations, and internal sites for service delivery. While adding new suppliers may feel counter to the traditional goal of supplier consolidation for lower prices, it may […]

What factors make this economic downturn different, and is IT services spending recession-proof? Despite recessionary fears, digital transformation and post-pandemic demand will help maintain IT services growth with more cautious tech spend moving forward. Learn the three strategies service providers […]

With increased competition and cost pressure in the property and casualty industry, insurers are rapidly modernizing technology and moving to the cloud. Top SaaS vendors like Guidewire and Duck Creek are playing increasingly important roles in insurers’ modernization journeys. Getting […]

Health systems are increasingly seeking competitive proposals post-pandemic to outsource Revenue Cycle Management (RCM) and get the best prices and innovation in contracts. Learn what enterprises want and how providers can win these RFPs.  Why has outsourcing gained traction in […]

Steeply climbing salaries and outsourcing rates, dwindling talent pools, and increasing customer expectations of service are causing organisations across Europe to feel the heat and break budgets when it comes to global services. Because these challenges will likely persist throughout […]

There’s no shortage of market discussion around a wide range of customer experience (CX) opportunities and challenges. It’s what everyone in your organization, from IT, to HR, to actual customer care, are talking about. But while ideas about what you […]

Shortly after the U.S. Food & Drug Administration (FDA) approved Novartis’ CAR T-cell drug, Kymriah – which is used for pediatric B-cell Acute Lymphoblastic Leukemia – last month, Novartis announced its price…a whopping $475,000 per patient. This is certainly not […]

The business environment in which today’s IT service providers are operating is one of the most challenging in recent times. A host of buy- and supply-side factors are impacting the prices they can feasibly and competitively charge their enterprise clients […]

Methods to manage demand variation in outsourcing contracts Visit the report page